Shanghai Universal Biotech Co.,Ltd. (SHE:301166)
China · Delayed Price · Currency is CNY 30.66
+0.36 (1.19%)
At close: Mar 30, 2026
SHE:301166 Market Cap
SHE:301166 has a market cap or net worth of 2.63 billion as of March 30, 2026. Its market cap has increased by 4.74% in one year.
Market Cap
2.63B
Enterprise Value
1.37B
Revenue
1.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
30.66
Market Cap Chart
Since December 28, 2021, SHE:301166's market cap has decreased from 9.10B to 2.63B, a decrease of -71.12%. That is a compound annual growth rate of -25.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 2.63B | 3.30% |
| Dec 31, 2025 | 2.54B | 3.97% |
| Dec 31, 2024 | 2.45B | -26.49% |
| Dec 29, 2023 | 3.33B | -15.99% |
| Dec 30, 2022 | 3.96B | -55.60% |
| Dec 31, 2021 | 8.93B | -1.94% |
| Dec 28, 2021 | 9.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Sihuan Bioengineering | 3.04B |
| Shanghai Hile Bio-Technology | 3.01B |
| Suzhou Fushilai Pharmaceutical | 2.85B |
| Novoprotein Scientific | 2.79B |
| Shanghai Serum Bio-Technology | 2.75B |
| Shandong Sito Bio-technology | 2.69B |
| Jilin Jian Yisheng Pharmaceutical | 2.67B |
| Hubei Goto Biopharm | 2.38B |